A Study of BL-M07D1 in Patients With HER2-expressing Recurrent or Metastatic Gynecologic Malignancies

NCT06131450 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

138

Enrollment

INDUSTRY

Sponsor class

Conditions

Gynecological Malignancies

Interventions

DRUG: BL-M07D1

Sponsor

Sichuan Baili Pharmaceutical Co., Ltd.

Collaborators

[object Object]